Clinical trial
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard…
NCT00388583 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00388583 |
|---|---|
| Title | Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects |
| Official title | Immunogenicity and Safety of The Split, Inactivated, Trivalent Influenza Vaccine Administered by Intradermal Route in Comparison With Intramuscular Vaccination With Standard Fluzone® in Ambulatory Elderly Subjects |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Orthomyxoviridae Infection, Influenza, Myxovirus Infection |
| Intervention type | Biological |
| Interventions | Split, Inactivated, Trivalent Influenza Vaccine |
| Enrollment | 817 |
| Start date | Sep 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Oct 17, 2006 |
| Last update posted | Apr 18, 2012 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: